James Patrick Nelli Jr. is President of Health Catalyst, Inc.. Currently has a direct ownership of 265,025 shares of HCAT, which is worth approximately $2.35 Million. The most recent transaction as insider was on Sep 01, 2022, when has been sold 3,359 shares (Common Stock) at a price of $11.61 per share, resulting in proceeds of $38,998. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 265K
0% 3M change
0% 12M change
Total Value Held $2.35 Million

James Patrick Nelli Jr. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 01 2022
SELL
Payment of exercise price or tax liability
$38,998 $11.61 p/Share
3,359 Reduced 1.25%
265,025 Common Stock
Jun 01 2022
SELL
Payment of exercise price or tax liability
$49,041 $14.6 p/Share
3,359 Reduced 1.24%
268,384 Common Stock
Mar 02 2022
SELL
Payment of exercise price or tax liability
$17,909 $26.69 p/Share
671 Reduced 0.25%
271,743 Common Stock
Mar 01 2022
SELL
Payment of exercise price or tax liability
$109,742 $26.63 p/Share
4,121 Reduced 1.56%
260,865 Common Stock
Mar 01 2022
BUY
Grant, award, or other acquisition
-
11,549 Added 4.07%
272,414 Common Stock
Feb 24 2022
BUY
Grant, award, or other acquisition
-
110,000 Added 29.33%
264,986 Common Stock
Feb 14 2022
BUY
Exercise of conversion of derivative security
$150,301 $10.69 p/Share
14,060 Added 8.32%
154,986 Common Stock
Dec 13 2021
BUY
Exercise of conversion of derivative security
$254,250 $10.17 p/Share
25,000 Added 15.07%
140,926 Common Stock
Dec 02 2021
SELL
Payment of exercise price or tax liability
$468,665 $41.95 p/Share
11,172 Reduced 8.79%
115,926 Common Stock
Sep 13 2021
SELL
Open market or private sale
$1,605,323 $54.64 p/Share
29,380 Reduced 18.78%
127,098 Common Stock
Sep 13 2021
BUY
Exercise of conversion of derivative security
$279,760 $10.76 p/Share
26,000 Added 14.25%
156,478 Common Stock
Sep 01 2021
SELL
Payment of exercise price or tax liability
$155,640 $54.23 p/Share
2,870 Reduced 2.15%
130,478 Common Stock
Jun 15 2021
SELL
Open market or private sale
$194,652 $56.75 p/Share
3,430 Reduced 2.51%
133,348 Common Stock
Jun 01 2021
SELL
Payment of exercise price or tax liability
$151,942 $53.88 p/Share
2,820 Reduced 2.02%
136,778 Common Stock
May 11 2021
SELL
Open market or private sale
$735,463 $49.68 p/Share
14,804 Reduced 9.59%
139,598 Common Stock
May 11 2021
BUY
Exercise of conversion of derivative security
$159,291 $10.76 p/Share
14,804 Added 8.75%
154,402 Common Stock
Mar 01 2021
SELL
Open market or private sale
$1,289,138 $49.11 p/Share
26,250 Reduced 15.83%
139,598 Common Stock
Mar 01 2021
BUY
Exercise of conversion of derivative security
$215,200 $10.76 p/Share
20,000 Added 10.76%
165,848 Common Stock
Feb 18 2021
BUY
Grant, award, or other acquisition
-
70,000 Added 32.43%
145,848 Common Stock
Dec 16 2020
SELL
Open market or private sale
$639,118 $40.04 p/Share
15,962 Reduced 17.39%
75,848 Common Stock
Dec 16 2020
BUY
Exercise of conversion of derivative security
$172,390 $10.8 p/Share
15,962 Added 14.81%
91,810 Common Stock
Dec 14 2020
SELL
Open market or private sale
$112,468 $40.01 p/Share
2,811 Reduced 3.57%
75,848 Common Stock
Dec 14 2020
BUY
Exercise of conversion of derivative security
$30,359 $10.8 p/Share
2,811 Added 3.45%
78,659 Common Stock
Dec 11 2020
SELL
Open market or private sale
$49,019 $39.95 p/Share
1,227 Reduced 1.59%
75,848 Common Stock
Dec 11 2020
BUY
Exercise of conversion of derivative security
$13,252 $10.8 p/Share
1,227 Added 1.57%
77,075 Common Stock
JPN

James Patrick Nelli Jr.

President
South Jordan, UT

Track Institutional and Insider Activities on HCAT

Follow Health Catalyst, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HCAT shares.

Notify only if

Insider Trading

Get notified when an Health Catalyst, Inc. insider buys or sells HCAT shares.

Notify only if

News

Receive news related to Health Catalyst, Inc.

Track Activities on HCAT